Join the club for FREE to access the whole archive and other member benefits.

Alex Zhavoronkov

CEO of InSilico Medicine & Deep Longevity. CSO of Biogerontology Research Foundation.

Dr. Zhavoronkov holds two bachelor degrees from Queen’s University, a master’s in Biotechnology from Johns Hopkins University, and a PhD in Physics and Mathematics from Moscow State University.

As at Sept-20: 313 Publications, 4,053 Citations

Prior to founding Insilico Medicine, he worked in senior roles at ATI Technologies (acquired by AMD in 2006), NeuroG Neuroinformatics, the Biogerontology Research Foundation and YLabs.AI and established AgeNet.net competitions and diversity.AI initiative.

Author of "The Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy", Palgrave Macmillan, NY, 2013 - available in English, Japanese, Chinese, and Polish.

Visit website: http://www.agelessbook.com/the-author-details/

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

See also: Company Insilico Medicine - Biotechnology company that uses artificial intelligence to develop new drugs and for aging research

Alex Zhavoronkov is also referenced in the following:

Event

Latest progress in the molecular, cellular and organismal basis of aging

Event

Online event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen chaired by Morten Scheibye-Knudsen, Daniela Bakula and Alex Zhavoronkov, and with many speakers.

Event

NUS Healthy Longevity webinar with Alex Zhavoronkov - CEO of Insilico Medicine

Event

AMA with Sergey Young, Alex Zhavoronkov and Sourav Sinha

Event

Workshop is part of ARDD 2021 conference that brings health care providers involved in longevity, organized by Cassandra Coburn and Evelyne Bischof. (FREE)

Event
Metabesity 2021
11-Oct-2021 to 14-Oct-2021

The Kitalys institute virtual conference targeting key questions that will impact the future of aging and extending healthspan

Alex Zhavoronkov Creations

Alex Zhavoronkov News

Deep Longevity's epigenetic aging clock, DeepMAge, retrained to use saliva samples

Longevity Technology - 02-Aug-2021

With an accuracy of 4.7 years it is much more convenient for home testing

Read more...

Insilico raises $255M to advance human trials and AI drug discovery platform

Longevity Technology - 22-Jun-2021

New collab with Teva Pharmaceuticals to identify drug targets for various diseases

Read more...

First-ever AI designed drug candidate for pulmonary fibrosis

Longevity Technology - 24-Feb-2021

Insilico's novel drug target is prepping for IND studies, expecting to start clinical studies by early 2022

Read more...

Super summary of 3rd Annual Longevity Therapeutics Summit

Lifespan.io (LEAF) - 16-Feb-2021

More and more companies making greater and greater progress - 2021 could be an exciting year

Read more...

AI based aging clock predicts psychological age

Longevity Technology - 16-Dec-2020

Deep longevity's psychological clock might help you feel younger and live longer

Read more...

Pharma company teams with AI to develop anti aging solutions

Longevity Technology - 15-Oct-2020

Taisho and Insilico collabs to identify novel targets for senolytic drugs

Read more...

Alex Zhavoronkov explains why AI can help in peer reviewing drug development research

Nature Biotechnology - 14-Sep-2020

An automated sense-check of publications sounds like a good idea

Read more...

New app helps identify biological age and methods to slow it down

Fortune - 17-Aug-2020

Apps such as Young. ai will play a key role in helping understand and reversing aging processes

Read more...

AI reduces drug discovery from years to days - and that's just the start

Singularity Hub - 23-Jul-2020

Insilico Medicine is slashing the cost of drug development

Read more...

Deep Longevity investors bet on growing need for aging and longevity biomarkers

FierceBiotech - 15-Jul-2020

Biological clocks are a moving target so they'll need other researchers to corroborate their analysis

Read more...

Should WHO use a new framework for the diagnosis and treatment of age-related diseases?

Lifespan.io (LEAF) - 08-May-2020

LEAF summarises and exchange of thoughts between leading aging researchers

Read more...

Proposed strategy to protect elderly from gerolavic infections like COVID-19

Forbes - 31-Mar-2020

To benefit long term global health and longevity, and enhance economic recovery

Read more...

Nanalyze looks at Insilico Medicine's AlphaGo moment in pharma

Nanalyze - 09-Oct-2019

From lab to clinic in 2 years instead of 10 would have a huge impact on health

Read more...

Insilico and ARK enter a research collaboration on health-span and longevity

EurekAlert! - 22-May-2019

AI-based methods, to explore mechanisms of ageing and improving health-span

Read more...

Gut microbiome predicts age with 4 year accuracy

Lifespan.io (LEAF) - 15-Jan-2019

It both affects and is affected by its host status

Read more...

Aging focused biotechs forms AI based joint venture

FierceBiotech - 14-Aug-2018

Groundbreaking research biotechs performs aging research together for longevity

Read more...

AgeX Identifies Genes Implicated in Regeneration and Cancer

Business Wire - 02-Jan-2018

Study that reveals genes implicated in tissue regeneration, cancer, and aging. Worked in collabo...

Read more...

AI-powered application to assess visual aging biomarkers in lab animals

Lifespan.io (LEAF) - 29-Aug-2017

Lifespan.io is launching a crowdfunding campaign to support MouseAGE. Software will assess visua...

Read more...

British billionaire gambles on an anti-aging upstart

Endpoints News - 26-Jul-2017

We are at an inflection point for the treatment of aging. We can generate molecules with specifi...

Read more...

AI Versus Aging

Lifespan.io (LEAF) - 18-Apr-2017

Interview with Dr. Alex Zhavoronkov, CEO of Insilico Medicine Company awarded the ‘Most Promisin...

Read more...

Display all news

Articles written by Alex Zhavoronkov

Artificial intelligence can revolutionise longevity medicine

Nature Aging - 14-Jan-2021

Collaboration among stakeholders can transform public health into public health longevity

Read more...